COMMUNIQUÉS West-GlobeNewswire

CRISPR Therapeutics to Participate in Three June Conferences
05/06/2018
ZUG, Switzerland and CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]
Aphios Granted United States Patent for Improved Delivery of Targeted siRNA Using Nanotechnology
05/06/2018
WOBURN, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been granted United States Patent No. 9,981,238 entitled “Apparatus and Methods for Making Nanosomes Loaded with Nucleic [...]
Resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” held on June 05th, 2018
05/06/2018
Resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” held on June 05th, 2018 Report of the Board on results of operations in 2017. To take notice of the Report of the Board of the JSC “Olainfarm [...]
Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Delivery
05/06/2018
NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
TG Therapeutics, Inc. to Present at the Jefferies 2018 Global Healthcare Conference
05/06/2018
Presentation scheduled for Thursday, June 7, 2018 at 10:30am ET NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and [...]
Solon Eiendom ASA : Primary insider notification
05/06/2018
(Oslo, Norway, June 04, 2018) UFI AS has today bought 26 458 shares in Solon Eiendom ASA at a price of NOK 30.20 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Results from Oasmia Pharmaceutical’s phase III study have been presented at ASCO annual meeting
05/06/2018
During Monday Oasmia Pharmaceutical AB presented the follow-up results from the completed phase III study with Apealea ® for treatment of ovarian cancer. Uppsala, Sweden, June 5, 2018 - The 2018 ASCO Annual Meeting is [...]
B-Temia to Showcase Keeogo at G7 Summit
05/06/2018
B-Temia / Keeogo invited to G7 Summit Innovation Experience QUÉBEC CITY, June 05, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotic tech company based in Quebec City and leader in the human mobility market is [...]
B-Temia présente le Keeogo au sommet du G7
05/06/2018
B-Temia / Keeogo est invité à l’Expérience Innovation du Sommet du G7 QUÉBEC, 05 juin 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., une entreprise canadienne de technologie biorobotique basée à Québec et leader sur le marché [...]
Saniona reports positive results from preclinical studies for Tesomet opening op for long-term clinical studies
05/06/2018
PRESS RELEASE June 5, 2018 Saniona, a leading biotech company within ion-channel research, today announced successful completion of the preclinical toxicology studies for Tesomet. The preclinical studies demonstrated [...]
DBV Technologies to Attend Upcoming Investor Conferences
05/06/2018
Montrouge, France, June 5, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs
05/06/2018
Montrouge, France, le 5 juin (7H30 CEST), 2018 DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]
ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018
05/06/2018
Amsterdam, The Netherlands - 05 June 2018 Esperite regrets to announce that due to the technical issues as reported on 30 April and despite the constant efforts provided by the different teams involved, additional time [...]
Basilea reports presentation of phase 1 clinical data with anticancer drug candidate BAL101553 at ASCO meeting
05/06/2018
Data support expansion into phase 2a Basel, Switzerland, June 05, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that data from the phase 1 dose-escalation parts of two phase 1/2a studies with weekly 48- [...]
Kiadis Pharma announces results of Annual General Meeting
05/06/2018
Kiadis Pharma announces results of Annual General Meeting Amsterdam, The Netherlands, June 5, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS ), a clinical stage [...]
FibroGen to Present at Two Upcoming Investor Conferences
04/06/2018
SAN FRANCISCO, June 04, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company, today announced that management will participate in a Fireside Chat at the Jefferies 2018 Healthcare Conference [...]
Kalytera Announces Next Monthly Payment in Shares under Services Agreement with Salzman Group
04/06/2018
SAN FRANCISCO and TEL AVIV, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to issue [...]
RadNet, Inc. to Present at the 8th Annual LD Micro Invitational on June 6th
05/06/2018
LOS ANGELES, June 04, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting
05/06/2018
TOPACIO data for ZEJULA ® (niraparib) in combination with an anti-PD-1 mAb highlight promising activity in platinum-resistant/refractory ovarian cancer and triple-negative breast cancer beyond patients with BRCA [...]

Pages